Conversion Strategy for Adderall IR to XR + IR Combination

Introduction to Conversion

• The American Academy of Child and Adolescent Psychiatry recommends a maximum total daily dose for amphetamines of 40mg, and clinical practice consensus limits the upper range to 40mg 1, 2

Dosing Recommendations

• For a patient currently taking 25mg IR twice daily, convert to Adderall XR 30mg in the morning plus Adderall IR 10mg at lunch, maintaining a total daily dose of 40mg within FDA-approved maximum limits 1, 2
• If symptom control at 40mg total daily dose proves inadequate, consider Adderall XR 30mg in the morning plus Adderall IR 15mg at lunch, which provides 45mg total daily dose, although this exceeds the FDA label maximum of 40mg 1, 3

Critical Timing Considerations

• Administer XR dose immediately upon awakening to ensure morning coverage 1
• The IR lunch dose must be given before 2:00 PM to prevent insomnia 1, 3

Important Monitoring Parameters

• Assess blood pressure and pulse at each follow-up visit, checking quarterly in adults 1, 2
• Monitor weight at every visit to assess for appetite suppression 1, 2
• Evaluate target ADHD symptoms using standardized rating scales 1
• Monitor for side effects, including insomnia, anorexia, headaches, mood changes, and cardiovascular effects 1, 2

Common Pitfalls to Avoid

• Do not exceed 40mg total daily dose without clear documentation that lower doses were ineffective 1, 2
• Do not give the IR dose after 2:00 PM as this commonly causes insomnia 1, 3
• Do not crush, chew, or divide XR capsules as this destroys the extended-release mechanism 4
• Higher doses increase cardiovascular risks, such as hypertension and tachycardia, and potential for tolerance/dependence 2

Alternative Treatment Options

• Consider switching to an alternative stimulant medication, such as methylphenidate formulations, if maximum dose proves ineffective 1, 2
• Add environmental or psychosocial interventions to treatment plan 1
• Explore non-stimulant medication options, including atomoxetine, guanfacine, and clonidine 2
• Reevaluate the diagnosis and consider comorbid conditions affecting treatment response 1